Scarica l'app Stockscreener
7.01
4.23%
-0.31
Precedente Chiudi:
$7.32
Aprire:
$7.1
Volume 24 ore:
1,566
Relative Volume:
0.05
Capitalizzazione di mercato:
$22.28M
Reddito:
-
Utile/perdita netta:
$-68.80M
Rapporto P/E:
-5.9915
EPS:
-1.17
Flusso di cassa netto:
$-59.06M
1 W Prestazione:
-8.49%
1M Prestazione:
-11.82%
6M Prestazione:
+1,675%
1 anno Prestazione:
+1,060%
Intervallo 1D:
$7.01
$7.10
Intervallo di 1 settimana:
$7.01
$7.91
Portata 52W:
$0.257
$9.00
Passage Bio Inc Stock (PASG) Company Profile
Nome
Passage Bio Inc
Settore
Industria
Telefono
(267) 866-0312
Indirizzo
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Confronta PASG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.01 | 23.27M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.43 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.39 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.27 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.73 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.48 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-29 | Ripresa | Wedbush | Outperform |
| 2024-09-03 | Iniziato | Rodman & Renshaw | Buy |
| 2022-03-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Downgrade | Goldman | Buy → Neutral |
| 2021-07-01 | Iniziato | Raymond James | Outperform |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-03-04 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-02-04 | Iniziato | Guggenheim | Buy |
| 2021-01-25 | Iniziato | Wedbush | Outperform |
| 2021-01-04 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Iniziato | Citigroup | Neutral |
| 2020-08-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2020-03-24 | Iniziato | Cowen | Outperform |
| 2020-03-24 | Iniziato | Goldman | Buy |
| 2020-03-24 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Passage Bio Inc Borsa (PASG) Ultime notizie
Market reaction to Passage Bio Inc.’s recent newsTrade Risk Assessment & Verified Swing Trading Watchlists - newser.com
Combining machine learning predictions for Passage Bio Inc.Dollar Strength & Weekly Setup with ROI Potential - newser.com
How Passage Bio Inc. stock reacts to Fed rate cutsJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
How to recover losses in Passage Bio Inc. stockStop Loss & Accurate Trade Setup Notifications - newser.com
Why Passage Bio Inc. stock remains a top recommendationJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com
Will Passage Bio Inc. price bounce be sustainableGDP Growth & Fast Gain Stock Trading Tips - newser.com
What momentum shifts mean for Passage Bio Inc.2025 Volatility Report & Verified Entry Point Signals - newser.com
Can Passage Bio Inc. stock attract ESG capital inflows2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Why Passage Bio Inc. is moving todayJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
Using economic indicators to assess Passage Bio Inc. potentialWeekly Profit Report & Free Daily Entry Point Trade Alerts - newser.com
Passage Bio Inc. stock trendline breakdown2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Is Passage Bio Inc. stock bottoming outJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
Applying chart zones and confluence areas to Passage Bio Inc.2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com
Why Passage Bio Inc. stock could rally in 2025Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - newser.com
Multi asset correlation models including Passage Bio Inc.2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
How Passage Bio Inc. stock reacts to global recession fearsJuly 2025 Big Picture & Low Drawdown Trading Techniques - newser.com
Smart tools for monitoring Passage Bio Inc.’s price action2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
Ocugen to Announce Third-Quarter 2025 Results and Business Update on November 5 - MyChesCo
Predicting Passage Bio Inc. trend using moving averagesJuly 2025 Analyst Calls & Short-Term High Return Ideas - newser.com
Can you recover from losses in Passage Bio Inc.2025 Market Overview & Precise Buy Zone Tips - newser.com
Ranking Passage Bio Inc. among high performing stocks via toolsWeekly Profit Report & Verified Swing Trading Watchlist - newser.com
Passage Bio Inc Azioni (PASG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.73%
0.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):